A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
Constellation Pharmaceuticals
Constellation Pharmaceuticals
Hangzhou GluBio Pharmaceutical Co., Ltd.
AbbVie
Astex Pharmaceuticals, Inc.
Eli Lilly and Company
Traws Pharma, Inc.
Galena Biopharma, Inc.
INSYS Therapeutics Inc